|
⚲
|
| Keyboard |
| GMS Tenshi Holdings Pte Ltd
✚
|
|
|---|---|
| CIK # | 0001716335 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001716335] | |
| 4 | [0001716335] | |
| SC 13D | [0001716335] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| GMS Tenshi Holdings PTE Ltd | Oncobiologics Inc | [2017-09-18] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| BioLexis Pte Ltd | |
| Outlook Therapeutics Inc | |
| Sukhtian Ghiath M | |
| Pillai Arun Kumar | |
| Sukhtian Faisal Ghiath |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2022-04-21 | Other | 27,982,529 | ||
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2020-03-23 | Option exercise | 29,358,621 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2020-03-23 | Option exercise | 68,112 | ||
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2020-03-19 | Disposed to issuer | 68,112 | ||
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2020-03-19 | Grant | 68,112 | ||
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-29 | Option exercise | 1,282,051 | $1.00 | 1,282,051 |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-29 | Option exercise | 2,093,750 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-29 | Option exercise | 1,282,051 | $1.00 | 1,282,051 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2020-01-29 | Option exercise | 4,657,852 | $0.23 | 1,071,306 |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-27 | Disposed to issuer | 1,282,051 | $1.00 | 1,282,051 |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-27 | Grant | 1,282,051 | $1.00 | 1,282,051 |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-27 | Disposed to issuer | 1,282,051 | $1.00 | 1,282,051 |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-27 | Disposed to issuer | 2,093,750 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-27 | Grant | 1,282,051 | $1.00 | 1,282,051 |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2020-01-27 | Grant | 2,093,750 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2019-12-31 | Other | 1,661 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Warrant (Right to Buy) · derivative
|
2019-12-23 | Option exercise | 3,636,364 | ||
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2019-12-23 | Option exercise | 2,909,091 | $0.23 | 669,091 |
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2019-09-30 | Other | 1,620 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Series A-1 Convertible Preferred Stock · derivative
|
2019-06-30 | Other | 1,581 | $0.00 | |
| showing 20 of 45 most recent transactions | |||||